| 1 | 3350-06-9 | 2-Cyclopenten-1-amine | C5H9N | 83.13 | | |
| 2 | 3350-13-8 | Z-DAB(BOC)-OH | C17H24N2O6 | 352.38 | 198-200℃ | Slightly soluble in water. |
| 3 | 3350-15-0 | H-DAB(BOC)-OME HCL | C10H21ClN2O4 | 268.74 | 167 °C | |
| 4 | 3350-19-4 | BOC-LEU-ONP | C17H24N2O6 | 352.38 | | |
| 5 | 3350-20-7 | Butanoic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]-4-[[(phenylmethoxy)carbonyl]a mino]-, (2S)- | C17H24N2O6 | 352.38 | | |
| 6 | 3350-21-8 | 11-amino- Undecanoic acid ethyl ester, hydrochloride (1:1) | C13H28ClNO2 | 265.82 | | |
| 7 | 3350-30-9 | Cyclononanone | C9H16O | 140.223 | | |
| 8 | 3350-55-8 | D-Valine, ethyl ester | C7H15NO2 | 145.2 | | |
| 9 | 3350-77-4 | 3-Butenoyl chloride, 3-Methyl- | C5H7ClO | 118.56 | | |
| 10 | 3350-78-5 | 3,3-Dimethylacryloyl chloride | C5H7ClO | 118.56 | | reacts |
| 11 | 33500-13-9 | 1,2,3,4,5-Pentachloro-6-[chloro(2,3,4,4,5,6-hexachloro-2,5-cyclohexadien-1-ylidene)methyl]benzene | | | | |
| 12 | 33500-15-1 | TERT-BUTANOL-1,1,1-D3 | C4H10O | 74.12 | | |
| 13 | 33500-20-8 | 2-[Bis(methylthio)methyl]furan | | | | |
| 14 | 33500-23-1 | 5-Hydroxy-4'-methoxy-7-methylflavone | | | | |
| 15 | 33500-78-6 | 1-Naphthalenecarboxylic acid, 8-bromo-, ethyl ester | C13H11BrO2 | 279.13 | | |
| 16 | 33500-88-8 | 1-Bromo-2-methoxy-4,5-dimethylbenzene | C9H11BrO | 215.09 | | |
| 17 | 335013-04-2 | 4-CHLORO-3-METHYLBENZOIC ACID ETHYL ESTER | C10H11ClO2 | 198.65 | | |
| 18 | 335013-18-8 | 4-Bromo-1-(bromomethyl)-2-(trifluoromethyl)benzene | C8H5Br2F3 | 317.93 | | |
| 19 | 335013-56-4 | 4-tert-Butyl-2-chloro-6-nitroaniline | C10H13ClN2O2 | 228.68 | | |
| 20 | 335013-90-6 | 4-Chloro-3-hydroxybenzoic Acid Ethyl Ester | C9H9ClO3 | 200.62 | | |
| 21 | 335015-51-5 | 4-BroMo-3-nitro-benzoyl chloride | C7H3BrClNO3 | 264 | | |
| 22 | 335017-46-4 | tert-Butyl Cetirizine | C25H33ClN2O3 | 444.99 | | |
| 23 | 33502-03-3 | (3-PHENOXY-2-OXOPROPYLIDENE)TRIPHENYLPHOSPHORANE | C27H23O2P | 410.44 | | |
| 24 | 335021-90-4 | INOSINE-(8-14C) 5'-MONOPHOSPHATE DIAMMONIUM SALT | C10H19N6O8P | 384.29 | | |
| 25 | 33503-72-9 | Guanosine Tetraphosphate | | | | |
| 26 | 335030-22-3 | Phenylalanine, N-[(1,1-diMethylethoxy)carbonyl]-4-(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)-, Methyl ester | C21H32BNO6 | 405.29 | | |
| 27 | 335030-24-5 | D-Phenylalanine, N-[(1,1-dimethylethoxy)carbonyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester | C21H32BNO6 | 405.29 | | |
| 28 | 335030-36-9 | 1 - (tert - butoxycarbonyl) - 1,2,3,4 - tetrahydro - 1,8 - naphthyridine | C13H18N2O2 | 234.29 | | |
| 29 | 335030-38-1 | TERT-BUTYL 6-BROMO-3,4-DIHYDRO-1,8-NAPHTHYRIDINE-1(2H)-CARBOXYLATE | C13H17BrN2O2 | 313.19 | | |
| 30 | 335030-65-4 | 2-Propenoic acid, 3-(3H-iMidazo[4,5-b]pyridin-6-yl)-, (2E)- | C9H7N3O2 | 189.17 | | |
| 31 | 335030-80-3 | (2E)-3-(2-Aminopyrimidin-5-yl)acrylic acid | C7H7N3O2 | 165.14 | | |
| 32 | 335031-01-1 | 2-Amino-5-bromopyridine-3-methanol | C6H7BrN2O | 203.04 | 137-140°C | |
| 33 | 335031-10-2 | 6-Bromo-1,2,3,4-tetrahydro-2-oxo-1,8-naphthyridine-3-carboxylic Acid Methyl Ester | C10H9BrN2O3 | 285.09 | | |
| 34 | 335031-37-3 | 1H-Indene-2-carboxamide, N,3-dimethyl- | C12H13NO | | | |
| 35 | 335031-44-2 | 1H-Indene-2-carboxamide, N-methyl- | C11H11NO | | | |
| 36 | 335031-67-9 | N-[(1-Methyl-1H-indol-2-yl)methyl]-cyclopropanamine | C13H16N2 | 200.28 | | |
| 37 | 335032-38-7 | 6-Bromo-1,4-dihydro-2H-pyrido-[2,3-d][1,3]oxazin-2-one | C7H5BrN2O2 | 229.03 | 237-239° | |
| 38 | 335032-41-2 | N-methyl-1-(3-methylbenzo[b]thiophen-2-yl)methanamine | C11H13NS | 191.29 | | |
| 39 | 335032-47-8 | (1-benzothien-2-ylmethyl)methylamine(SALTDATA: HCl) | C10H11NS | 177.26604 | | |
| 40 | 335032-50-3 | N-Methyl-N-[(2-methyl-1H-indol-3-yl)methyl]amine | C11H14N2 | 174.24 | | |
| 41 | 335032-57-0 | methyl 6-methoxy-1-methyl-1H-indole-2-carboxylate | C12H13NO3 | 219.24 | | |
| 42 | 335032-69-4 | 1,5-Dimethyl-1H-indole-3-carbaldehyde | C11H11NO | 173.21 | | |
| 43 | 335033-38-0 | 5-BROMO-3-(BROMOMETHYL)PYRIDIN-2-AMINE HYDROBROMIDE | C6H7Br3N2 | 346.85 | | |
| 44 | 335033-68-6 | N-METHYL-N-[(4-METHYL-4H-THIENO[3,2-B]PYRROL-5-YL)METHYL]AMINE HYDROCHLORIDE | C9H13ClN2S | 216.73 | | |
| 45 | 335034-66-7 | Benzamide, 2,4-dimethoxy-N-[2-methyl-1-[[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]carbonyl]propyl]- (9CI) | C24H30N2O4 | 410.506 | | |
| 46 | 33504-43-7 | 2,4,6-Cycloheptatrien-1-one,amino- (8CI) | C7H7NO | 121.139 | | |
| 47 | 33504-66-4 | methylethylpyrazine,2-ethyl-6(or5)-methylpyrazine | C7H10N2 | 122.1677 | | |
| 48 | 335059-37-5 | 2-Furanmethanol,tetrahydro-5-methoxy-3,3-dimethyl-(9CI) | C8H16O3 | 160.21084 | | |
| 49 | 335059-62-6 | 1H-Pyrrole-2-carboxylic acid, 4-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-1-methyl-, 1,1-dimethylethyl ester | C25H26N2O4 | 418.48 | 105-107 °C | |
| 50 | 335059-71-7 | 1H-Pyrrole-2-carboxylicacid,4-amino-1-methyl-,1,1-dimethylethylester(9CI) | C10H16N2O2 | 196.25 | | |
| 51 | 335059-94-4 | Carbamic acid, N-[2-[[(4-chlorophenyl)methyl]-amino]ethyl]-, 1,1-dimethylethyl ester | C14H21ClN2O2 | 284.78 | | |
| 52 | 335060-45-2 | 2-Benzofuranacetic acid, 3-(4-hydroxy-3,5-diiodobenzoyl)-, (1R)-1-methylpropyl ester | C21H18I2O5 | 604.17 | | |
| 53 | 33507-06-1 | 2-AMINO-4-(4-CHLOROANILINO)-1-METHYL-6-OXO-1,6-DIHYDRO-5-PYRIMIDINYLFORMAMIDE | C12H12ClN5O2 | 293.71 | | |
| 54 | 33507-15-2 | 2-Benzofuranmethanamine, 7-chloro-2,3-dihydro-, hydrochloride (1:1) | C9H11Cl2NO | 220.09 | | |
| 55 | 33507-63-0 | SUBSTANCE P | C63H98N18O13S | 1347.63 | 148 °C | Soluble in water, DMSO, and Acetic Acid. |
| 56 | 33507-82-3 | (R,R)-(+)-1,4-DIMETHOXY-2,3-BUTANEDIOL | C6H14O4 | 150.17 | 28-30 °C | |
| 57 | 33507-94-7 | 1,3-Propanedione, 1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenyl- | C17H16O5 | 300.31 | | |
| 58 | 335077-89-9 | 2-(2-methylpropoxy)pyridine-3-carboxylic acid | C10H13NO3 | 195.22 | | |
| 59 | 335078-07-4 | 2-Ethoxy-5-iodopyridine-3-carboxylic acid | C8H8INO3 | 293.06 | | |
| 60 | 335078-23-4 | 3-Pyridinecarboxylicacid,5-acetyl-2-ethoxy-(9CI) | C10H11NO4 | 209.19864 | | |
| 61 | 335078-24-5 | Methyl 2-ethoxy-5-iodonicotinate | C9H10INO3 | 307.09 | | |
| 62 | 33508-02-0 | 1H-Indene, 2,3-dihydro-1,1,2-trimethyl-3-phenyl- | C18H20 | 236.35 | | |
| 63 | 33508-19-9 | (2R,3R,4S,5R)-2-AMino-3,4,5,6-tetrahydroxyhexanal sulfate | C6H15NO9S | 277.24 | | |
| 64 | 33508-55-3 | 3-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-o-tolyl]azo]naphthalene-1,5-disulphonic acid | C20H14Cl2N6O6S2 | 569.39776 | | |
| 65 | 33508-66-6 | β-D-Glucopyranoside, tetradecyl | C20H40O6 | 376.53 | | |
| 66 | 33508-79-1 | 1-(2,3-dihydro-3-oxo-1H-indazol-6-yl)-3-(hexadec-2-enyl)pyrrolidine-2,5-dione | C27H39N3O3 | 453.61686 | | |
| 67 | 335080-22-3 | NEURODYE RGA-30, PURE | C27H32N4O6S2.C6H15N | 673.895 | | |
| 68 | 335080-41-6 | Salivaricin B | C120H182N34O36S4 | 2805.22 | | |
| 69 | 335080-94-9 | 2-(3,4-DIHYDROXYPHENYL-13C6)ETHYLAMINE HCL | C8H12ClNO2 | 195.69 | | |
| 70 | 335080-96-1 | ARACHIDIC ACID-1-13C | C20H40O2 | 313.54 | | |
| 71 | 335080-97-2 | CHOLESTEROL-25,26,27-13C3 | C27H46O | 389.68 | 147-149 °C(lit.) | |
| 72 | 335080-98-3 | [Carboxy-13C]-2-Aminobenzoic acid | | | | |
| 73 | 335081-01-1 | CREATINE-(GUANIDINO-13C) MONOHYDRATE | C4H9N3O2 | 132.14 | 292°C (dec.)(lit.) | |
| 74 | 335081-02-2 | L-ALANINE-13C3, N-T-BOC DERIVATIVE (99 & | C8H15NO4 | 192.176 | 79-83°C(lit.) | |
| 75 | 335081-04-4 | DOPAMINE HYDROCHLORIDE | C8H12ClNO2 | 189.64 | 248-250°C(lit.) | |
| 76 | 335081-05-5 | 2,4'-DIBROMOACETOPHENONE-2-13C | C8H6Br2O | 278.95 | | |
| 77 | 335081-06-6 | Anthranilic Acid-13C6 | C7H7NO2 | 143.18998 | | |
| 78 | 335081-08-8 | 2-AMINOFLUORENE-9-13C | C13H11N | 182.24 | | |
| 79 | 335081-12-4 | 4,6-DICHLORO-1,3-DINITROBENZENE-13C6 | C6H2Cl2N2O4 | 243.05 | | |
| 80 | 335084-02-1 | Pyrimidine, 5-(1-propynyl)- (9CI) | C7H6N2 | 118.14 | | |
| 81 | 33509-43-2 | 4-Amino-6-(tert-butyl)-3-mercapto-1,2,4-triazin-5(4H)-one | C7H12N4OS | 200.26 | | |
| 82 | 33509-64-7 | BETA-METHYL-D-LYXOPYRANOSIDE | | | | |
| 83 | 33509-76-1 | Ethanone, 1-(6-chloro-2-benzothiazolyl)- (9CI) | C9H6ClNOS | 211.66804 | | |
| 84 | 33509-81-8 | 1-Butyl-4-hexyl-1,2,3,4-tetrahydronaphthalene | | | | |
| 85 | 335096-46-3 | D-Glucitol, 1-(4-hydroxybenzoate) | C13H18O8 | 302.28 | | |
| 86 | 335097-03-5 | TETRA-N-BUTYLAMMONIUM L-LACTATE | C19H41NO3 | 331.53 | | |